Health Economics and Outcomes Research (HEOR)
A discipline that evaluates the clinical, economic, and patient-reported value of healthcare interventions to inform coverage, pricing, and treatment decisions. Pharma and device companies use HEOR evidence to support payer negotiations and demonstrate real-world cost-effectiveness.
What is Health Economics and Outcomes Research (HEOR)?
Health Economics and Outcomes Research (HEOR) is a field that studies the value of medical treatments by weighing their clinical results against their costs and their effect on patients' daily lives. It blends economics, epidemiology, biostatistics, and patient-reported data to answer a practical question: does a given drug, device, or procedure deliver enough benefit to justify what it costs?
Analysts in this field build cost-effectiveness models, run budget-impact analyses, and gather real-world evidence from claims and registries. The output is meant to inform decisions about coverage, pricing, and which therapies earn a place on a formulary or in a treatment pathway.
Why does HEOR matter in healthcare?
Pharmaceutical and medical-device manufacturers lean on HEOR evidence when they negotiate with payers and governments, because a strong economic case can be the difference between broad reimbursement and a narrow one. Payers, in turn, use the same body of evidence to decide what they are willing to pay for and under what conditions.
As reimbursement across the industry shifts toward rewarding value rather than volume, the demand for credible outcomes data keeps growing. HEOR helps connect the dots between a treatment's price tag and the real benefit patients and the system receive in return.
- heor meaning
- health economics and outcomes research
- what is heor
- heor in pharma
- heor vs rwe
- outcomes research definition
- health economics outcomes research